126 related articles for article (PubMed ID: 38683228)
1. Comparative evaluation of hesperetin-loaded graphene oxide nanosheets (Hsp-GO) as a drug delivery system for colon cancer: synthesis and anticancer efficiency assessment.
Hadi AS; Haghi M; Barzegar A; Ali M; Feizi H
Mol Biol Rep; 2024 Apr; 51(1):591. PubMed ID: 38683228
[TBL] [Abstract][Full Text] [Related]
2. Hesperidin loaded Zn
Yang Z; Yang H; Dong X; Pu M; Ji F
J Photochem Photobiol B; 2020 Mar; 204():111767. PubMed ID: 32006893
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induction in colon cancer cells (SW480) by BiFe
Golrokh FJ; Tolami HF; Ghanbarirad M; Mahmoudi A; Tabassi NR; Alkinani TA; Taramsari SM; Aghajani S; Taati H; Akbari F; Noveiri MJS; Hedayati M; Ghasemipour T; Salehzadeh A
J Trace Elem Med Biol; 2024 May; 83():127369. PubMed ID: 38176316
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene.
Gurunathan S; Han JW; Park JH; Eppakayala V; Kim JH
Int J Nanomedicine; 2014; 9():363-77. PubMed ID: 24453487
[TBL] [Abstract][Full Text] [Related]
5. Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.
Yuan YG; Wang YH; Xing HH; Gurunathan S
Int J Nanomedicine; 2017; 12():5819-5839. PubMed ID: 28860751
[TBL] [Abstract][Full Text] [Related]
6. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
Javanbakht S; Pooresmaeil M; Namazi H
Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
[TBL] [Abstract][Full Text] [Related]
7. Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.
Gurunathan S; Han JW; Kim ES; Park JH; Kim JH
Int J Nanomedicine; 2015; 10():2951-69. PubMed ID: 25931821
[TBL] [Abstract][Full Text] [Related]
8. Chitosan biopolymer functionalized with graphene oxide and titanium dioxide with Escin metallic nanocomposites for anticancer potential against colon cancer.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Azlina MFN; Arulselvan P
Int J Biol Macromol; 2023 Dec; 253(Pt 7):127334. PubMed ID: 37820908
[TBL] [Abstract][Full Text] [Related]
9. A Novel Biomolecule-Mediated Reduction of Graphene Oxide: A Multifunctional Anti-Cancer Agent.
Choi YJ; Kim E; Han J; Kim JH; Gurunathan S
Molecules; 2016 Mar; 21(3):375. PubMed ID: 26999102
[TBL] [Abstract][Full Text] [Related]
10. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid.
Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283
[TBL] [Abstract][Full Text] [Related]
11. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231).
Gurunathan S; Han J; Park JH; Kim JH
Int J Nanomedicine; 2014; 9():1783-97. PubMed ID: 24741313
[TBL] [Abstract][Full Text] [Related]
12. Bovine α-lactalbumin functionalized graphene oxide nano-sheet exhibits enhanced biocompatibility: A rational strategy for graphene-based targeted cancer therapy.
Mahanta S; Paul S
Colloids Surf B Biointerfaces; 2015 Oct; 134():178-87. PubMed ID: 26196090
[TBL] [Abstract][Full Text] [Related]
13. Design and Characterization of Chitosan-Graphene Oxide Nanocomposites for the Delivery of Proanthocyanidins.
Figueroa T; Aguayo C; Fernández K
Int J Nanomedicine; 2020; 15():1229-1238. PubMed ID: 32110019
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of Graphene Oxide (GO) and Graphene Oxide Conjugated Losartan Potassium (GO-LP) on Neuroblastoma (NB41A3) Cells.
Kaur R; Verma S; Joshi P; Singh SP; Singh M
J Nanosci Nanotechnol; 2018 Oct; 18(10):6765-6775. PubMed ID: 29954492
[TBL] [Abstract][Full Text] [Related]
15. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
[TBL] [Abstract][Full Text] [Related]
16. Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.
Verde V; Longo A; Cucci LM; Sanfilippo V; Magrì A; Satriano C; Anfuso CD; Lupo G; La Mendola D
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759830
[TBL] [Abstract][Full Text] [Related]
17. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
[TBL] [Abstract][Full Text] [Related]
18. Graphene oxide-methylene blue nanocomposite in photodynamic therapy of human breast cancer.
Hosseinzadeh R; Khorsandi K; Hosseinzadeh G
J Biomol Struct Dyn; 2018 Jul; 36(9):2216-2223. PubMed ID: 28681663
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells.
Ersoz M; Erdemir A; Duranoglu D; Uzunoglu D; Arasoglu T; Derman S; Mansuroglu B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):319-329. PubMed ID: 30688095
[TBL] [Abstract][Full Text] [Related]
20. PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.
Jafarizad A; Taghizadehgh-Alehjougi A; Eskandani M; Hatamzadeh M; Abbasian M; Mohammad-Rezaei R; Mohammadzadeh M; Toğar B; Jaymand M
Biomed Mater Eng; 2018; 29(2):177-190. PubMed ID: 29457592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
